Crossmark

Direct Activation of Protein Phosphatase 2A (PP2A) by Tricyclic Sulfonamides Ameliorates Alzheimer's Disease Pathogenesis in Cell and Animal Models

Crossref DOI link: https://doi.org/10.1007/s13311-020-00841-6

Published Print: 2020-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Wei, Hui

Zhang, Hui-liang

Wang, Xiao-chuan

Xie, Jia-zhao

An, Dan-dan

Wan, Lu

Wang, Jian-zhi

Zeng, Yi

Shu, Xi-ji

Westermarck, Jukka

Lu, You-ming

Ohlmeyer, Michael

Liu, Rong https://orcid.org/0000-0001-7477-6520
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (31970964)

National Natural Science Foundation of China (31771189)

Natural Science Foundation of Hubei Province (2017CFA065)

Fundamental Research Funds for Central Universities, HUST (2019kfyXKJC079)
License Information

Text and Data Mining valid from 2020-07-01

Text and Data Mining valid from 2020-07-01

Version of Record valid from 2023-08-18
More Information

This article is maintained by: Elsevier

Article Title: Direct Activation of Protein Phosphatase 2A (PP2A) by Tricyclic Sulfonamides Ameliorates Alzheimer's Disease Pathogenesis in Cell and Animal Models

Journal Title: Neurotherapeutics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-020-00841-6

Content Type: article

Copyright: Copyright © 2020 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.